Clinical Trial Update: Pre-Operative Window of ET to Inform RT Decisions (POWER II) [Phase 3]

View source ↗

Summary

A Phase 3 trial (POWER II) sponsored by the University of Virginia is testing a pre-operative window of endocrine therapy to guide radiotherapy decisions in wom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: University of Virginia | Conditions: Breast Cancer Female | Phase 3 | Status: RECRUITING